BRPI9912266B8 - composto derivado da 6-desóxi eritromicina, bem como medicamentos e composições farmacêuticas contendo os mesmos. - Google Patents
composto derivado da 6-desóxi eritromicina, bem como medicamentos e composições farmacêuticas contendo os mesmos.Info
- Publication number
- BRPI9912266B8 BRPI9912266B8 BRPI9912266A BR9912266A BRPI9912266B8 BR PI9912266 B8 BRPI9912266 B8 BR PI9912266B8 BR PI9912266 A BRPI9912266 A BR PI9912266A BR 9912266 A BR9912266 A BR 9912266A BR PI9912266 B8 BRPI9912266 B8 BR PI9912266B8
- Authority
- BR
- Brazil
- Prior art keywords
- well
- drugs
- pharmaceutical compositions
- compositions containing
- compound derived
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- ZUGIGWIPEYNYJV-FZWPAWTOSA-N (3r,4s,5r,6s,7s,9r,11r,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@H](C)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ZUGIGWIPEYNYJV-FZWPAWTOSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Natural products O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 229960003276 erythromycin Drugs 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
patente de invenção: <b>"derivados da 6-desóxi eritromicina, processo de preparação dos mesmos e aplicação dos mesmos como medicamentos"<d>. a invenção tem por objetivo os compostos de fórmula (i) nos quais: x representa um radical (nh)a, ch~ 2~ ou so~ 2~ ou um átomo de oxigênio, a representa o número 0 ou 1, y representa um radical (ch~ 2~)m-(ch=ch) n-(ch~ 2~)o com m+n+o <243> 8, n = 0 ou 1, ar representa um radical arila ou heteroarila, eventualmente substituído, w representa um átomo de hidrogênio ou um átomo de halogênio, z representa um átomo de hidrogênio ou o resto de um ácido assim como sais de adição do mesmo com os ácidos. os compostos de fórmula (i) apresentam propriedades antibióticas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9809259A FR2781484B1 (fr) | 1998-07-21 | 1998-07-21 | Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments |
PCT/FR1999/001769 WO2000005239A1 (fr) | 1998-07-21 | 1999-07-20 | Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments |
Publications (3)
Publication Number | Publication Date |
---|---|
BR9912266A BR9912266A (pt) | 2001-04-17 |
BR9912266B1 BR9912266B1 (pt) | 2013-05-14 |
BRPI9912266B8 true BRPI9912266B8 (pt) | 2021-05-25 |
Family
ID=9528813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9912266A BRPI9912266B8 (pt) | 1998-07-21 | 1999-07-20 | composto derivado da 6-desóxi eritromicina, bem como medicamentos e composições farmacêuticas contendo os mesmos. |
Country Status (23)
Country | Link |
---|---|
US (1) | US6706692B1 (pt) |
EP (1) | EP1098901B1 (pt) |
JP (1) | JP4583601B2 (pt) |
KR (1) | KR20010071993A (pt) |
CN (1) | CN1359386A (pt) |
AT (1) | ATE231161T1 (pt) |
AU (1) | AU761551B2 (pt) |
BR (1) | BRPI9912266B8 (pt) |
CA (1) | CA2338172C (pt) |
CZ (1) | CZ2001237A3 (pt) |
DE (1) | DE69904940T2 (pt) |
DK (1) | DK1098901T3 (pt) |
EA (1) | EA003776B1 (pt) |
ES (1) | ES2188193T3 (pt) |
FR (1) | FR2781484B1 (pt) |
HU (1) | HUP0103997A3 (pt) |
IL (1) | IL140976A0 (pt) |
MX (1) | MXPA01000559A (pt) |
NO (1) | NO20010332L (pt) |
PT (1) | PT1098901E (pt) |
TR (1) | TR200100178T2 (pt) |
WO (1) | WO2000005239A1 (pt) |
ZA (1) | ZA200100566B (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE340183T1 (de) * | 1999-04-16 | 2006-10-15 | Kosan Biosciences Inc | Antiinfektiöse makrolidderivate |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5141926A (en) * | 1990-04-18 | 1992-08-25 | Abbott Laboratories | Erythromycin derivatives |
IL114589A (en) * | 1990-11-21 | 1999-12-22 | Roussel Uclaf | Intermediates for the preparation of the history of erythromycin |
FR2692579B1 (fr) * | 1992-06-19 | 1995-06-02 | Roussel Uclaf | Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments. |
FR2697524B1 (fr) * | 1992-11-05 | 1994-12-23 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
US5527780A (en) * | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
FR2719587B1 (fr) * | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
US6274715B1 (en) * | 1995-11-08 | 2001-08-14 | Abbott Laboratories | Tricyclic erythromycin derivatives |
US5747466A (en) * | 1995-11-08 | 1998-05-05 | Abbott Laboratories | 3-deoxy-3-descladinose derivatives of erythromycins A and B |
FR2742757B1 (fr) * | 1995-12-22 | 1998-01-30 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
FR2745290B1 (fr) * | 1996-02-28 | 1998-04-03 | Roussel Uclaf | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
IL126624A0 (en) * | 1996-05-07 | 1999-08-17 | Abbott Lab | 3-descladinose-2, 3-anhydroerythromycin derivatives |
FR2751656B1 (fr) * | 1996-07-24 | 1998-10-16 | Hoechst Marion Roussel Inc | Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments |
WO2000062783A2 (en) * | 1999-04-16 | 2000-10-26 | Ortho-Mcneil Pharmaceutical, Inc. | Ketolide antibacterials |
-
1998
- 1998-07-21 FR FR9809259A patent/FR2781484B1/fr not_active Expired - Fee Related
-
1999
- 1999-07-20 TR TR2001/00178T patent/TR200100178T2/xx unknown
- 1999-07-20 CZ CZ2001237A patent/CZ2001237A3/cs unknown
- 1999-07-20 CN CN99808934A patent/CN1359386A/zh active Pending
- 1999-07-20 DE DE69904940T patent/DE69904940T2/de not_active Expired - Lifetime
- 1999-07-20 CA CA2338172A patent/CA2338172C/fr not_active Expired - Lifetime
- 1999-07-20 EP EP99932916A patent/EP1098901B1/fr not_active Expired - Lifetime
- 1999-07-20 PT PT99932916T patent/PT1098901E/pt unknown
- 1999-07-20 WO PCT/FR1999/001769 patent/WO2000005239A1/fr not_active Application Discontinuation
- 1999-07-20 AT AT99932916T patent/ATE231161T1/de not_active IP Right Cessation
- 1999-07-20 KR KR1020017000839A patent/KR20010071993A/ko not_active Application Discontinuation
- 1999-07-20 AU AU49132/99A patent/AU761551B2/en not_active Ceased
- 1999-07-20 HU HU0103997A patent/HUP0103997A3/hu unknown
- 1999-07-20 EA EA200100163A patent/EA003776B1/ru not_active IP Right Cessation
- 1999-07-20 IL IL14097699A patent/IL140976A0/xx unknown
- 1999-07-20 BR BRPI9912266A patent/BRPI9912266B8/pt not_active IP Right Cessation
- 1999-07-20 DK DK99932916T patent/DK1098901T3/da active
- 1999-07-20 ES ES99932916T patent/ES2188193T3/es not_active Expired - Lifetime
- 1999-07-20 US US09/744,320 patent/US6706692B1/en not_active Expired - Lifetime
- 1999-07-20 MX MXPA01000559A patent/MXPA01000559A/es unknown
- 1999-07-20 JP JP2000561195A patent/JP4583601B2/ja not_active Expired - Lifetime
-
2001
- 2001-01-19 ZA ZA200100566A patent/ZA200100566B/xx unknown
- 2001-01-19 NO NO20010332A patent/NO20010332L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CZ2001237A3 (cs) | 2001-10-17 |
MXPA01000559A (es) | 2002-04-08 |
FR2781484A1 (fr) | 2000-01-28 |
NO20010332D0 (no) | 2001-01-19 |
TR200100178T2 (tr) | 2002-10-21 |
NO20010332L (no) | 2001-03-20 |
JP2003534231A (ja) | 2003-11-18 |
ZA200100566B (en) | 2002-12-24 |
DE69904940D1 (de) | 2003-02-20 |
ES2188193T3 (es) | 2003-06-16 |
US6706692B1 (en) | 2004-03-16 |
EA200100163A1 (ru) | 2001-08-27 |
BR9912266B1 (pt) | 2013-05-14 |
CA2338172A1 (fr) | 2000-02-03 |
WO2000005239A1 (fr) | 2000-02-03 |
JP4583601B2 (ja) | 2010-11-17 |
CN1359386A (zh) | 2002-07-17 |
FR2781484B1 (fr) | 2001-08-10 |
IL140976A0 (en) | 2002-02-10 |
DE69904940T2 (de) | 2003-08-28 |
HUP0103997A2 (hu) | 2002-02-28 |
BR9912266A (pt) | 2001-04-17 |
ATE231161T1 (de) | 2003-02-15 |
KR20010071993A (ko) | 2001-07-31 |
PT1098901E (pt) | 2003-06-30 |
DK1098901T3 (da) | 2003-05-05 |
HU0103997D0 (en) | 2001-11-28 |
HUP0103997A3 (en) | 2003-11-28 |
EA003776B1 (ru) | 2003-08-28 |
EP1098901A1 (fr) | 2001-05-16 |
AU761551B2 (en) | 2003-06-05 |
EP1098901B1 (fr) | 2003-01-15 |
AU4913299A (en) | 2000-02-14 |
CA2338172C (fr) | 2010-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0213242A (pt) | Composto ou um seu sal ou solvato, composto e seus sais de adição de ácido fisiologicamente aceitáveis, composição farmacêutica, método de tratamento de um ou mais distúrbios, uso de um composto, e, processo de preparação de um composto | |
TR200002796T2 (tr) | Aminosikloheksil eter bileşikleri ve bunların kullanımları. | |
EE200300417A (et) | Asendatud aminometüülrühma sisaldavad N-(arüülsulfonüül)beetaaminohappe derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
TR200003632T2 (tr) | Benzotiyepin-1,1-dioksid türevleri, üretim yöntemi, bunları içeren ilaçlar. | |
BR9915967A (pt) | Derivados de propanolamina substituìdos por arila, proceso para sua preparação, medicamentos contendo estes compostos e seu uso | |
TR200002953T2 (tr) | İki halkalı hidroksamik asit türevleri | |
FI941987A (fi) | Uudet aminohappojohdannaiset, menetelmät niiden valmistamiseksi ja näitä yhdisteitä sisältävät farmaseuttiset koostumukset | |
BR0212069A (pt) | Agentes antidiabéticos orais | |
HUP0001164A2 (hu) | PF1022-ciklodepszipeptid-származékok | |
RU2003103101A (ru) | Плеуромутилиновые производные, обладающие антибактериальной активностью | |
DE60024857D1 (de) | Neue verbindungen | |
BR9813217A (pt) | Tetraciclos, processo para a produção dos mesmos e preparações farmacêuticas contendo estes compostos | |
BR9813779A (pt) | Novos derivados do taxano | |
BRPI9912266B8 (pt) | composto derivado da 6-desóxi eritromicina, bem como medicamentos e composições farmacêuticas contendo os mesmos. | |
HUP0204501A2 (hu) | Gyűrűs vegyületek, ezeket tartalmazó gyógyászati készítmények, valamint eljárás a vegyületek előállítására és alkalmazásuk | |
BR9801448A (pt) | Compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos. | |
BR9809643A (pt) | Compostos heterocìclicos, seu processo de preparo e as composições farmacêuticas que os contêm | |
BR9714007A (pt) | Novos derivados da eritromicina seu processo de preparação e sua aplicação como medicamentos | |
HUP0202832A2 (hu) | Új pirimidin-2,4,6-trion-származékok, alkalmazásuk, valamint az e vegyületeket tartalmazó gyógyászati készítmények | |
BRPI9710537B8 (pt) | derivados da eritromicina, composições farmacêuticas, bem como processo para preparação dos mesmos. | |
BR9807795A (pt) | Derivados da eritromicina, seu processo de preparo e sua aplicação como medicamentos | |
RU2002124524A (ru) | Производные n-деацетилтиоколхицина и содержащие их фармацевтические композиции | |
BR0007348A (pt) | Uréias cìclicas ou lineares, processo para seupreparo e composições farmacêuticas contendo asmesmas | |
BR9809578A (pt) | Esteróides 4-halogenados, seu processo e intermediários de preparação, sua aplicação como medicamentos e as composições farmacêuticas que os contêm | |
ATE299027T1 (de) | Verwendung von übersulfatierten polysacchariden als hiv-hemmer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 14/05/2013, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/07/1999 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 20/07/2019 |